These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23084445)

  • 1. Magnesium for aneurysmal subarachnoid haemorrhage.
    Takeuchi S; Wada K; Nagatani K; Otani N; Mori K
    Lancet; 2012 Oct; 380(9851):1381; author reply 1382. PubMed ID: 23084445
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnesium for aneurysmal subarachnoid haemorrhage.
    Wong GK
    Lancet; 2012 Oct; 380(9851):1381; author reply 1382. PubMed ID: 23084444
    [No Abstract]   [Full Text] [Related]  

  • 3. Magnesium and neuroprotection in subarachnoid haemorrhage.
    Venkatasubba Rao CP; Suarez JI
    Lancet; 2012 Jul; 380(9836):9-11. PubMed ID: 22633826
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.
    Dorhout Mees SM; Algra A; Vandertop WP; van Kooten F; Kuijsten HA; Boiten J; van Oostenbrugge RJ; Al-Shahi Salman R; Lavados PM; Rinkel GJ; van den Bergh WM;
    Lancet; 2012 Jul; 380(9836):44-9. PubMed ID: 22633825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.
    Wong GK; Poon WS; Chan MT; Boet R; Gin T; Ng SC; Zee BC;
    Stroke; 2010 May; 41(5):921-6. PubMed ID: 20378868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correspondence to 'dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage'.
    Wong GK; Chan MT; Boet R; Poon WS
    J Clin Pharm Ther; 2006 Aug; 31(4):407. PubMed ID: 16882114
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnesium sulphate for aneurysmal subarachnoid hemorrhage: why, how, and current controversy.
    Wong GK; Poon WS
    Acta Neurochir Suppl; 2013; 115():45-8. PubMed ID: 22890642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: time for a paradigm shift?
    Gupta VK
    Stroke; 2005 Dec; 36(12):2530. PubMed ID: 16304138
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of intravenous magnesium sulfate infusion on serum levels of sodium and potassium in patients with aneurysmal subarachnoid hemorrhage.
    Wong GK; Poon WS; Chan MT; Boet R; Gin T; Lam CW
    Magnes Res; 2007 Mar; 20(1):37-42. PubMed ID: 17536487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial design in "magnesium sulphate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial".
    Wong GK; Boet R; Poon WS; Chan MT
    Stroke; 2005 Dec; 36(12):2530-1; author reply 2531-2. PubMed ID: 16282545
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of magnesium sulfate infusion on cerebral perfusion in patients after aneurysmal SAH.
    Wong GK; Kwok R; Tang K; Yeung D; Ahuja A; King AD; Poon WS
    Acta Neurochir Suppl; 2010; 106():133-5. PubMed ID: 19812935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials.
    Ma L; Liu WG; Zhang JM; Chen G; Fan J; Sheng HS
    Brain Inj; 2010; 24(5):730-5. PubMed ID: 20334471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous magnesium in subarachnoid hemorrhage.
    Abdo WF; Hoedemaekers CW; van der Hoeven JG
    Crit Care; 2011; 15(3):427; author reply 427. PubMed ID: 21631908
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular-biological basics of neuroprotection effects of magnesium].
    Gromova OA; Torshin IIu; Kalacheva AG; Kuramshina DB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):90-101. PubMed ID: 22590776
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group.
    Dorhout Mees SM;
    Int J Stroke; 2008 Feb; 3(1):63-5. PubMed ID: 18705917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
    Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K
    Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea.
    Wong GK; Chan MT; Poon WS; Boet R; Gin T
    Neurol Res; 2006 Jun; 28(4):431-5. PubMed ID: 16759446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium in subarachnoid haemorrhage: proven beneficial?
    van den Bergh WM
    Magnes Res; 2009 Sep; 22(3):121-6. PubMed ID: 19780398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of hypermagnesemic treatment on cerebrospinal fluid magnesium level in patients with aneurysmal subarachnoid hemorrhage.
    Wong GK; Lam CW; Chan MT; Gin T; Poon WS
    Magnes Res; 2009 Jun; 22(2):60-5. PubMed ID: 19658274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous magnesium therapy in adult patients with an aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.
    Yarad EA; Hammond NE
    Aust Crit Care; 2013 Aug; 26(3):105-17. PubMed ID: 23806874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.